Font Size:
a
A
A
Keyword [PD-1/PD-L1 inhibitors]
Result: 21 - 40 | Page: 2 of 3
21.
Echocardiographic Evaluation Of The Effects Of PD-1/PD-L1 Inhibitors On Left Ventricular Systolic Function In Cancer Patients
22.
Evaluation Of The Effects Of PD-1/PD-L1 Inhibitors On Right Ventricular Function Using Echocardiography
23.
Efficacy And Safety Of PD-1/PD-L1 Inhibitors Versus Chemotherapy In Second-line Treatment Of Advanced Esophageal Cancer:A Meta-Analysis Of Randomized Controlled Trials
24.
A Meta-analysis Of The Efficacy And Safety Of PD-1/PD-L1 Inhibitors In The Treatment Of Advanced Gastric Cancer
25.
Research Progress Of PD-1/PD-L1 Inhibitors In Combined Therapy In Advanced Colorectal Cancer
26.
PD-1/PD-L1 Inhibitors Vs.chemotherapy For Previously Treated Advanced Gastroesophageal Cancer:A Meta-analysis Of Randomized Controlled Trials
27.
Efficacy And Safety Of PD-1/PD-L1 Inhibitors Plus Chemotherapy For Triple Negative Breast Cancer:A Systematic Review And Meta-analysis
28.
Evaluation Of PD-1/PD-L1 Inhibitor Combination Therapy Regimens In Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma:A Network Meta-analysis
29.
Molecular Simulations Of PD-1/PD-L1 Complex And De Novo Molecular Design Of Small Chemical Inhibitors
30.
Design,Synthesis And Biological Activity Evaluation Of Small Molecule PD-1/PD-L1 Inhibitors Of Novel Resorcinol Dibenzyl Ether Analogues
31.
Safety And Efficacy Of PD-1/PD-L1 Inhibitors In Patients With Malignant Tumors Associated With Hepatitis Virus Infection In A Real World Study
32.
Efficacy And Safety Of PD-1/PD-L1 Inhibitors In Advanced Solid Tumors
33.
Assessment And Prediction Of PD-1/PD-L1 Inhibitors Associated Early Cardiotoxicity In Patients With Lung Cancer Using Cardiac Magnetic Resonance
34.
The Association Between BIM Deletion And Therapeutic Efficacy Of Osimertinib、PD-1/PD-L1 Inhibitors In NSCLC
35.
Efficacy And Safety Of PD-1/PD-L1 Inhibitors Combinationtherapy In Advanced Colorectal Cancer:A Meta Analysis
36.
Correlation Analysis Between HBsAg/HBV DNA And Prognosis Of Patients With HBV Related Hepatocellular Carcinoma Treated With PD-1/PD-L1 Inhibitors
37.
Meta-analysis Of Clinical Efficacy For PD-1/PD-L1 Inhibitors In Elderly Patients With Advanced Non-small Cell Lung Cancer
38.
Prognostic Significance Of NLR, PLR And Lymphocyte Subsets For First-line PD-1/PD-L1 Inhibitors In The Treatment Of Extensive Stage-small Cell Lung Cancer
39.
Efficacy And Safety Of PD-1/PD-L1 Inhibitors Combined With Lenvatinib As First-line Treatment For Patients With Advanced Biliary Tract Carcinoma Who Are Intolerant To Or Refuse Chemotherapy
40.
Meta-analysis Of The Influence Of Concomitant Gastric Acid Suppressants Use On The Survival Of Patients With Non-small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors
<<First
<Prev
Next>
Last>>
Jump to